oxazolidin-2-one has been researched along with Skin Diseases, Bacterial in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 28 (43.08) | 29.6817 |
2010's | 30 (46.15) | 24.3611 |
2020's | 7 (10.77) | 2.80 |
Authors | Studies |
---|---|
Broyde, N; Chou, MZ; De Anda, CS; Duval, V; Feng, HP; Guiastrennec, B; Hardalo, C; Li, D; Ouerdani, A; Rizk, ML; Sabato, PE; Sears, PS | 1 |
De Anda, C; Fujimi, S; Kusachi, S; Mikamo, H; Nagashima, M; Oshima, N; Takase, A | 1 |
Huang, H; Yuan, H; Yuan, Z; Zhang, Y; Zhao, X | 1 |
Calabuig Muñoz, E; Castells Lao, G; Isernia, V; López Suñé, E; Mensa Pueyo, J; Mensa Vendrell, M; Morata Ruiz, L; Moreno Nuñez, L; Oltra Sempere, MR; Pasquau Liaño, J; Pedro-Botet Montoya, ML; Reynaga Sosa, EA; Salavert Lletí, M; Sequera Arquelladas, S; Soriano Viladomiu, A; Tasias Pitarch, M; Yuste Ara, JR | 1 |
Carena, AA; Stryjewski, ME | 1 |
Antadze, T; Bradley, JS; Broyde, N; Butterton, JR; Chou, MZ; De Anda, CS; Kim, JY; Ninov, B; Sears, PS; Tayob, MS | 1 |
Kase, M; Kitaoka, A; Kobayashi, S; Matsubara, M; Yasu, T | 1 |
Bensaci, M; Corey, R; De Anda, C; Goering, R; Moran, G; Prokocimer, P; Sandison, T | 1 |
Antão, HS; Froes, F; Gonçalves-Pereira, J; Guimarães, JP; Santos, FP | 1 |
Chen, X; Dong, BR; Liu, GJ; Wu, T; Yang, M; Yue, J | 1 |
Bien, P; De Anda, C; Prokocimer, P | 1 |
Boucher, HW; Das, AF; Dunne, MW; Puttagunta, S; Talbot, GH; Wilcox, M | 1 |
Corey, GR; Das, AF; De Anda, C; Fang, E; Moran, GJ; Prokocimer, P | 1 |
Kern, WV; Tacconelli, E | 1 |
Fan, W; Kongnakorn, T; LaPensee, KT; Pelligra, CG; Revankar, N; Ward, AJ | 1 |
Fiedler-Kelly, J; Flanagan, S; Lu, Q; Ludwig, E; Passarell, J; Prokocimer, P | 1 |
Holmes, NE; Howden, BP | 1 |
Steiner, M | 1 |
Corey, GR; Das, AF; De Anda, C; Fang, E; Lodise, TP; Prokocimer, P; Shorr, AF | 1 |
Drekonja, DM | 2 |
Taylor, J | 1 |
Corey, GR; Das, AF; Moran, GJ; Prokocimer, P | 1 |
Cardona, AF; Wilson, SE | 1 |
Anuskiewicz, S; Culshaw, D; De Anda, C; Joseph, WS; Prokocimer, P | 1 |
Ferrández, O; Grau, S; Urbina, O | 1 |
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
Bouza, E; Croos-Dabrera, RV; Herr, DL; Ijzerman, MM; Knirsch, C; Kunkel, MJ; Ruf, BR; Tack, KJ; Wilcox, MH | 1 |
Lustberg, ME; Mangino, JE; Schlesinger, LS | 1 |
Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
Stein, GE; Wells, EM | 1 |
Concia, E | 1 |
Curcio, D | 1 |
Ang, JY; Deville, JG; Equils, O; Huang, DB | 1 |
Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J | 1 |
Gould, FK | 1 |
Clark, K; Corey, GR; Craft, JC; Das, A; Degenhardt, TP; Fernandes, P; Moriarty, SR; Scott, D; Still, JG | 1 |
Lin, YH; Liu, TC | 1 |
Almenoff, J; Andrae, D; Covington, P; Davenport, JM; Liverman, L; McIntyre, G; O'Riordan, W | 1 |
Dowzicky, MJ; Namdari, H; Tan, TY | 1 |
Arbeit, RD; Draper, MP; Hait, H; Noel, GJ; Tanaka, SK | 1 |
Hau, T | 1 |
Arya, SC | 1 |
Bruss, JB; Cammarata, SK; Le, V; Solomkin, JS; Wilson, SE | 1 |
Li, JZ; Rittenhouse, BE; Rybak, MJ; Willke, RJ | 1 |
Gauzit, R | 1 |
Scheinfeld, NS; Schweiger, ES; Tischler, HR; Weinberg, JM | 1 |
Adler, S; Bruss, JB; Edge-Padbury, B; Kaplan, SL; Martin, A; Morfin, MR; Naberhuis-Stehouwer, S; Patterson, LE; Yogev, R | 1 |
Bruss, JB; Edge-Padbury, B; Goldfarb, J; Kaplan, SA; Naberhuis-Stehouwer, S; Saiman, L; Wible, K | 1 |
Choi, SH; Gonzalez, E; Vera-Cabrera, L; Welsh, O | 1 |
Schweiger, ES; Weinberg, JM | 1 |
LaRosa, SP; Tomecki, KJ | 1 |
Chen, YS; Kim, WJ; Lee, SC | 1 |
Lerner, DS; Silverberg, NB; Weinberg, JM; Wesson, KM | 1 |
Kyle, SD; Porter, WM | 1 |
Citron, DM; Goldstein, EJ; Havlichek, DH; Kak, V; Peloquin, CA; Schooley, SL; Stein, GE; Tyrrell, KL | 1 |
Dryden, M; Itani, K; Knirsch, C; Lau, W; Stevens, D; Weigelt, J | 1 |
Wilcox, MH | 1 |
Babazadeh, S; Breaux, J; Endzinas, Z; Frederick, M; Goldberg, L; Jauregui, LE; Krause, D; Krievins, D; O'Riordan, W; Satilovs, I; Seltzer, E | 1 |
Charles, PG; Grayson, ML; Howden, BP; Johnson, PD; Ward, PB | 1 |
Scheinfeld, N | 1 |
Plouffe, JF | 1 |
Bruss, JB; Duvall, SE; Hafkin, B; McConnell-Martin, MA; Smith, LG; Stevens, DL; Todd, WM | 1 |
Hedström, SA | 1 |
20 review(s) available for oxazolidin-2-one and Skin Diseases, Bacterial
Article | Year |
---|---|
Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections.
Topics: Animals; Anti-Bacterial Agents; Drug Interactions; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles | 2020 |
Linezolid versus vancomycin for skin and soft tissue infections.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Eruptions; Humans; Length of Stay; Linezolid; Oxazolidinones; Pruritus; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Thrombocytopenia; Vancomycin | 2013 |
What's new in the treatment of serious MRSA infection?
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2014 |
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Daptomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; North America; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections | 2015 |
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Oxazolidinones; Skin Diseases, Bacterial; Streptococcus; Tetrazoles | 2017 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
[Therapy of SSTI and role of tigecycline].
Topics: Acetamides; Anti-Bacterial Agents; Combined Modality Therapy; Comorbidity; Cross Infection; Daptomycin; Debridement; Drainage; Drug Therapy, Combination; Humans; Italy; Linezolid; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Tigecycline; Wound Infection | 2009 |
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Skin Diseases, Bacterial; Tigecycline; Treatment Outcome | 2010 |
Linezolid: safety and efficacy in special populations.
Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United Kingdom | 2011 |
Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Humans; Linezolid; Multicenter Studies as Topic; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
Topics: Acetamides; Anti-Bacterial Agents; Biological Availability; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Half-Life; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Virginiamycin | 2003 |
Novel antibacterial agents for skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Oxazolidinones; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Virginiamycin | 2004 |
Antibiotics: what's new?
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Streptogramins | 2004 |
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Half-Life; Humans; Linezolid; Metabolic Clearance Rate; Oxazolidinones; Skin Diseases, Bacterial; Virginiamycin | 2004 |
Update on linezolid: the first oxazolidinone antibiotic.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Teicoplanin; Vancomycin | 2005 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2000 |
[Linezolide--an antibiotic with new action mechanism].
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
22 trial(s) available for oxazolidin-2-one and Skin Diseases, Bacterial
Article | Year |
---|---|
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing ted
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Double-Blind Method; Hospitals; Humans; Japan; Linezolid; Organophosphates; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Skin Diseases, Bacterial; Tetrazoles; Ventilators, Mechanical | 2022 |
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response.
Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Humans; Linezolid; Oxazolidinones; Pyridones; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome | 2022 |
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Female; Global Health; Humans; Male; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Tetrazoles; Wound Infection | 2021 |
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.
Topics: Acetamides; Anti-Bacterial Agents; Erythema; Humans; Image Interpretation, Computer-Assisted; Linezolid; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; United States | 2014 |
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
Topics: Acetamides; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Teicoplanin; Vancomycin; Young Adult | 2014 |
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
Topics: Acetamides; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Young Adult | 2014 |
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Skin Infections; Tetrazoles | 2015 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Vancomycin | 2009 |
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pediatrics; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2011 |
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2011 |
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
Topics: Acetamides; Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Cellulitis; Double-Blind Method; Drug Administration Schedule; Female; Fusidic Acid; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Young Adult | 2011 |
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcus aureus; Treatment Outcome; United States; Young Adult | 2011 |
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Minocycline; Oxazolidinones; Placebos; Skin; Skin Diseases, Bacterial; Staphylococcal Infections; Treatment Outcome | 2012 |
Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Length of Stay; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Probability; Prognosis; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcus aureus; Treatment Outcome; Vancomycin; Wound Infection | 2003 |
Linezolid for the treatment of complicated skin and skin structure infections in children.
Topics: Acetamides; Administration, Oral; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Safety and tolerability of linezolid in children.
Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefadroxil; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Gram-Positive Bacterial Infections; Headache; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Multicenter Studies as Topic; Otitis Media; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Skin Diseases, Bacterial | 2003 |
Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens.
Topics: Acetamides; Cellulitis; Consumer Product Safety; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Protein Synthesis Inhibitors; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Cellulitis; Drug Resistance, Multiple, Bacterial; Female; Half-Life; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Obesity; Oxazolidinones; Serum Bactericidal Test; Skin Diseases, Bacterial; Soft Tissue Infections | 2005 |
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Female; Humans; Internationality; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Teicoplanin; Time Factors | 2005 |
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.
Topics: Acetamides; Anti-Infective Agents; Dicloxacillin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxacillin; Oxazolidinones; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome | 2000 |
23 other study(ies) available for oxazolidin-2-one and Skin Diseases, Bacterial
Article | Year |
---|---|
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Humans; Oxazolidinones; Probability; Skin Diseases, Bacterial; Tetrazoles | 2021 |
Safety and Tolerability of More than Six Days of Tedizolid Treatment.
Topics: Anti-Bacterial Agents; Humans; Organophosphates; Oxazoles; Oxazolidinones; Retrospective Studies; Skin Diseases, Bacterial; Tetrazoles | 2020 |
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.
Topics: Anti-Bacterial Agents; Humans; Linezolid; Microbial Sensitivity Tests; Neutropenia; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Tetrazoles | 2021 |
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Tetrazoles; Treatment Outcome; Young Adult | 2019 |
Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Anti-Infective Agents; Comorbidity; Female; Humans; Length of Stay; Male; Middle Aged; Oxazolidinones; Patient Discharge; Portugal; Retrospective Studies; Skin Diseases, Bacterial; Thrombocytopenia | 2019 |
New antibiotics for skin and skin-structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2014 |
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.
Topics: Acetamides; Acute Disease; Administration, Intravenous; Anti-Bacterial Agents; Daptomycin; Health Expenditures; Humans; Linezolid; Oxazolidinones; Patient Discharge; Skin Diseases, Bacterial; Soft Tissue Infections; United States; Vancomycin | 2014 |
Tedizolid population pharmacokinetics, exposure response, and target attainment.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Organophosphates; Oxazoles; Oxazolidinones; Platelet Count; Prodrugs; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Young Adult | 2014 |
Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2014 |
A closer inspection of tedizolid.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2015 |
A closer inspection of tedizolid.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2015 |
A closer inspection of tedizolid - authors' reply.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2015 |
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity Infections
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Tetrazoles; Treatment Outcome | 2017 |
Noninferiority of linezolid for skin and bloodstream infections.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biomedical Research; Catheterization; Humans; Linezolid; Oxazolidinones; Research Design; Skin Diseases, Bacterial | 2009 |
Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study".
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Catheterization; Humans; Linezolid; Oxazolidinones; Skin Diseases, Bacterial | 2009 |
Mycobacterium chelonae infection involving the auricle.
Topics: Acetamides; Adult; Anti-Infective Agents; Clarithromycin; Ear Auricle; Humans; Linezolid; Lymph Nodes; Lymphadenitis; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Neck; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome | 2012 |
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
Topics: Acetamides; Acinetobacter baumannii; Carbapenems; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Humans; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Skin; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2012 |
Therapeutic efficacy of linezolid in extended clinical practice.
Topics: Acetamides; Anti-Infective Agents; Drug Labeling; Drug Storage; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Assessment; Sensitivity and Specificity; Skin Diseases, Bacterial; Soft Tissue Infections; Temperature | 2003 |
A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Cloxacillin; Female; Humans; Linezolid; Male; Middle Aged; Outcome Assessment, Health Care; Oxazolidinones; Penicillins; Prognosis; Risk; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Failure | 2003 |
[Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues].
Topics: Acetamides; Anti-Infective Agents; Controlled Clinical Trials as Topic; France; Humans; Linezolid; Oxacillin; Oxazolidinones; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections | 2003 |
In vitro activities of new antimicrobials against Nocardia brasiliensis.
Topics: Anti-Infective Agents; Humans; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Oxazolidinones; Skin Diseases, Bacterial; Sulfonamides | 2004 |
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Forearm; Humans; Linezolid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Oxazolidinones; Skin Diseases, Bacterial | 2004 |
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
Topics: Acetamides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |